A study published in the Journal of the National Comprehensive Cancer Network found that only a small percentage of men recommended for genetic testing due to personal or family history of cancer actually received it. The study evaluated 7,894 men with incident pancreatic, breast, or metastatic prostate cancers and found low testing rates of 18% among commercially insured men and 14.2% among those treated in the VA system. The study also identified racial disparities in testing rates, with Black men less likely to undergo genetic testing. Strategies to address this problem include improving insurance coverage, reducing costs, and increasing access to telegenetics services.
Source link
Men with cancer history often do not receive recommended genetic testing
